Cipla’s arm enters into definitive agreement with Biopharma SPA

08 Oct 2015 Evaluate

Cipla’s wholly owned subsidiary - Cipla (EU), has entered into a definitive agreement with Biopharma SPA for establishing a joint venture company in Algeria.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1507.65 7.55 (0.50%)
02-Jan-2026 10:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.70
Dr. Reddys Lab 1246.90
Cipla 1507.65
Zydus Lifesciences 914.10
Lupin 2106.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×